Find Lauromacrogol manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

Australia

0

South Africa

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

192RELATED EXCIPIENT COMPANIES

314EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Exclusivities

API/FDF Prices: Book a Demo

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56,59,62,65,68,71,74,77,80-heptacosaoxadooctacontan-82-ol, Chebi:44817, 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol, Q27120584
Molecular Formula
C55H112O28
Molecular Weight
1221.5  g/mol
InChI Key
ISGUIIHZEJGUGQ-UHFFFAOYSA-N

Lauromacrogol
1 2D Structure

Lauromacrogol

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol
2.1.2 InChI
InChI=1S/C55H112O28/c1-57-4-5-59-8-9-61-12-13-63-16-17-65-20-21-67-24-25-69-28-29-71-32-33-73-36-37-75-40-41-77-44-45-79-48-49-81-52-53-83-55-54-82-51-50-80-47-46-78-43-42-76-39-38-74-35-34-72-31-30-70-27-26-68-23-22-66-19-18-64-15-14-62-11-10-60-7-6-58-3-2-56/h56H,2-55H2,1H3
2.1.3 InChI Key
ISGUIIHZEJGUGQ-UHFFFAOYSA-N
2.1.4 Canonical SMILES
COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56,59,62,65,68,71,74,77,80-heptacosaoxadooctacontan-82-ol

2. Chebi:44817

3. 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol

4. Q27120584

2.3 Create Date
2006-01-26
3 Chemical and Physical Properties
Molecular Weight 1221.5 g/mol
Molecular Formula C55H112O28
XLogP3-4.4
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count28
Rotatable Bond Count80
Exact Mass1220.73401291 g/mol
Monoisotopic Mass1220.73401291 g/mol
Topological Polar Surface Area269 Ų
Heavy Atom Count83
Formal Charge0
Complexity1070
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

API SUPPLIERS

read-more
read-more

01

Sumitomo Seika Chemicals

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Health 2.0 Conference
Not Confirmed
arrow

Sumitomo Seika Chemicals

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Health 2.0 Conference
Not Confirmed
USDMF arrow-down Click Us! arrow-down
CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

02

NOF CORPORATION

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Health 2.0 Conference
Not Confirmed
arrow

NOF CORPORATION

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Health 2.0 Conference
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

03

NOF CORPORATION

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Health 2.0 Conference
Not Confirmed
arrow

NOF CORPORATION

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Health 2.0 Conference
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

04

NOF CORPORATION

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Health 2.0 Conference
Not Confirmed
arrow

NOF CORPORATION

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Health 2.0 Conference
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

05

NOF CORPORATION

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Health 2.0 Conference
Not Confirmed
arrow

NOF CORPORATION

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Health 2.0 Conference
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

06

NOF CORPORATION

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Health 2.0 Conference
Not Confirmed
arrow

NOF CORPORATION

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Health 2.0 Conference
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

07

NOF CORPORATION

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Health 2.0 Conference
Not Confirmed
arrow

NOF CORPORATION

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Health 2.0 Conference
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

08

NOF CORPORATION

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Health 2.0 Conference
Not Confirmed
arrow

NOF CORPORATION

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Health 2.0 Conference
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

09

The Dow Chemical Company

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Health 2.0 Conference
Not Confirmed
arrow

The Dow Chemical Company

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Health 2.0 Conference
Not Confirmed
USDMF CEP/COS JDMF arrow-down EU-WC NDC KDMF VMF Others AUDIT arrow-down
blank

10

Country

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Health 2.0 Conference
Not Confirmed
arrow

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Health 2.0 Conference
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

01

Nof Corp

Japan

USDMF

arrow
Health 2.0 Conference
Not Confirmed

01

Nof Corp

Japan
arrow
Health 2.0 Conference
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 35636

Submission : 2021-03-02

Status : Active

Type : II

blank

02

Nof Corp

Japan

USDMF

arrow
Health 2.0 Conference
Not Confirmed

02

Nof Corp

Japan
arrow
Health 2.0 Conference
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 28678

Submission : 2014-09-26

Status : Active

Type : II

blank

03

Nof Corp

Japan

USDMF

arrow
Health 2.0 Conference
Not Confirmed

03

Nof Corp

Japan
arrow
Health 2.0 Conference
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 21153

Submission : 2007-12-17

Status : Active

Type : II

blank

04

Nof Corp

Japan

USDMF

arrow
Health 2.0 Conference
Not Confirmed

04

Nof Corp

Japan
arrow
Health 2.0 Conference
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 29524

Submission : 2015-06-30

Status : Active

Type : II

blank

05

Nof Corp

Japan

USDMF

arrow
Health 2.0 Conference
Not Confirmed

05

Nof Corp

Japan
arrow
Health 2.0 Conference
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 27603

Submission : 2013-10-01

Status : Active

Type : II

blank

06

Nof Corp

Japan

USDMF

arrow
Health 2.0 Conference
Not Confirmed

06

Nof Corp

Japan
arrow
Health 2.0 Conference
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 29335

Submission : 2015-04-27

Status : Active

Type : II

blank

07

Nof Corp

Japan

USDMF

arrow
Health 2.0 Conference
Not Confirmed

07

Nof Corp

Japan
arrow
Health 2.0 Conference
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 22570

Submission : 2009-02-23

Status : Active

Type : II

blank

08

IPhEB Russia
Not Confirmed
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

JDMF

read-more
read-moreread-more

01

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Polyethylene oxide

Registration Number : 218MF20001

Registrant's Address : 2211 H. H. Dow Way, Midland MI 48674, United States

Initial Date of Registration : 2006-02-23

Latest Date of Registration : 2023-06-21

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

read-more
read-moreread-more

01

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Macrogols EP

Date of Issue : 2025-10-17

Valid Till : 2028-08-04

Written Confirmation Number : WC-0234

Address of the Firm : Plot No. 2, Gut No. 189/1, 189/2, 191/2, 191/6,\r\n194, 165/3, 166, 167, 168 and...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-moreread-more

01

Avesta Pharma Private Limited

Country
Health 2.0 Conference
Not Confirmed
arrow

Avesta Pharma Private Limited

Country
arrow
Health 2.0 Conference
Not Confirmed

POLYETHYLENE GLYCOL 6000

NDC Package Code : 57449-011

Start Marketing Date : 2023-05-01

End Marketing Date : 2027-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

02

LARKSPUR ENTERPRISES LLC

Country
Health 2.0 Conference
Not Confirmed
arrow

LARKSPUR ENTERPRISES LLC

Country
arrow
Health 2.0 Conference
Not Confirmed

POLYETHYLENE GLYCOL 6000

NDC Package Code : 87126-017

Start Marketing Date : 2025-12-01

End Marketing Date : 2049-12-01

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

PEG 6000

About the Company : Avesta Pharma Pvt. Ltd. is a new state of the art facility for the manufacture of Polyethylene Glycol (Macrogol) pharma grade.The plant is designed as per ICHQ-7, EU-GMP and US FDA...

Avesta Pharma Pvt. Ltd. is a new state of the art facility for the manufacture of Polyethylene Glycol (Macrogol) pharma grade.The plant is designed as per ICHQ-7, EU-GMP and US FDA guidelines. Plant is dedicated for manufacturing PEG’s of various molecular weights as per EP/USP-NF. Our state-of-the-art manufacturing facility consist of the most advanced testing equipments to provide utmost assurance on the quality of our products. Equipment is tested and certified, and every manufacturing process is validated. All vendors are audited and approved to guarantee that only the highest grade materials are used in our products.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Flag India
Digital Content Digital Content

Regulatory Info : RX

Registration Country : USA

POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS

Brand Name : POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES

Dosage Form : FOR SOLUTION;ORAL

Dosage Strength : 236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/BOT;22.74GM/BOT

Packaging :

Approval Date : 2018-12-21

Application Number : 204558

Regulatory Info : RX

Registration Country : USA

Strides Pharma Science

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Flag India
Digital Content Digital Content

Regulatory Info : RX

Registration Country : USA

POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE

Brand Name : PEG-3350, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDE

Dosage Form : FOR SOLUTION;ORAL

Dosage Strength : 420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/BOT

Packaging :

Approval Date : 2015-04-13

Application Number : 204559

Regulatory Info : RX

Registration Country : USA

Strides Pharma Science

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Flag India
Digital Content Digital Content

Regulatory Info :

Registration Country : India

Polyethylene Glycol 4000

Brand Name : Polyethylene Glycol 4000

Dosage Form : PFOS

Dosage Strength : 10G

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Strides Pharma Science

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Flag India
Digital Content Digital Content

Regulatory Info :

Registration Country : India

Polyethylene Glycol 4000

Brand Name : Polyethylene Glycol 4000

Dosage Form : PFOS

Dosage Strength : 4G

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Strides Pharma Science

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

Flag Israel
Digital Content Digital Content

Regulatory Info : DISCN

Registration Country : USA

POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS

Brand Name : GLYCOPREP

Dosage Form : FOR SUSPENSION;ORAL

Dosage Strength : 236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/BOT;22.74GM/BOT

Packaging :

Approval Date : 1988-12-23

Application Number : 72319

Regulatory Info : DISCN

Registration Country : USA

TAPI Company Banner

06

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS

Brand Name : COLYTE

Dosage Form : FOR SOLUTION;ORAL

Dosage Strength : 227.1GM/PACKET;2.82GM/PACKET;6.36GM/PACKET;5.53GM/PACKET;21.5GM/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1984-10-26

Application Number : 18983

Regulatory Info : DISCN

Registration Country : USA

blank

07

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS

Brand Name : COLYTE

Dosage Form : FOR SOLUTION;ORAL

Dosage Strength : 120GM/PACKET;1.49GM/PACKET;3.36GM/PACKET;2.92GM/PACKET;11.36GM/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1984-10-26

Application Number : 18983

Regulatory Info : DISCN

Registration Country : USA

blank

08

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS

Brand Name : COLYTE

Dosage Form : FOR SOLUTION;ORAL

Dosage Strength : 360GM/PACKET;4.47GM/PACKET;10.08GM/PACKET;8.76GM/PACKET;34.08GM/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1984-10-26

Application Number : 18983

Regulatory Info : DISCN

Registration Country : USA

blank

09

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS

Brand Name : COLYTE

Dosage Form : FOR SOLUTION;ORAL

Dosage Strength : 240GM/BOT;2.98GM/BOT;6.72GM/BOT;5.84GM/BOT;22.72GM/BOT **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1987-06-12

Application Number : 18983

Regulatory Info : DISCN

Registration Country : USA

blank

10

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS

Brand Name : COLYTE-FLAVORED

Dosage Form : FOR SOLUTION;ORAL

Dosage Strength : 227.1GM/BOT;2.82GM/BOT;6.36GM/BOT;5.53GM/BOT;21.5GM/BOT **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1991-11-14

Application Number : 18983

Regulatory Info : DISCN

Registration Country : USA

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

read-more
read-more

01

NORGINE ITALIA Srl

Netherlands
Health 2.0 Conference
Not Confirmed
arrow

NORGINE ITALIA Srl

Netherlands
arrow
Health 2.0 Conference
Not Confirmed

Lauromacrogol

Brand Name : Kleanprep

Dosage Form :

Dosage Strength : 4 Bust Groun Os 70 Mg  

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Parenteral

read-more
read-more

Coating Systems & Additives

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Taste Masking

read-more
read-more

Topical

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Solubilizers

read-more
read-more

Direct Compression

read-more
read-more

Controlled & Modified Release

read-more
read-more

API Stability Enhancers

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Emulsifying Agents

read-more
read-more

Granulation

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Empty Capsules

read-more
read-more

Co-Processed Excipients

read-more
read-more

Vegetarian Capsules

read-more
read-more

Rheology Modifiers

read-more
read-more

Lubricants & Glidants

read-more
read-more

Coloring Agents

read-more
read-more

Soft Gelatin

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ANALYTICAL

Upload your methods for free, ask us

Analytical Methods

read-more
read-more

ABOUT THIS PAGE

Looking for / Lauromacrogol API manufacturers, exporters & distributors?

Lauromacrogol manufacturers, exporters & distributors 1

32

PharmaCompass offers a list of Lauromacrogol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Lauromacrogol manufacturer or Lauromacrogol supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lauromacrogol manufacturer or Lauromacrogol supplier.

PharmaCompass also assists you with knowing the Lauromacrogol API Price utilized in the formulation of products. Lauromacrogol API Price is not always fixed or binding as the Lauromacrogol Price is obtained through a variety of data sources. The Lauromacrogol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Lauromacrogol

Synonyms

2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56,59,62,65,68,71,74,77,80-heptacosaoxadooctacontan-82-ol, Chebi:44817, 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol, Q27120584

PEG 8000 Manufacturers

A PEG 8000 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of PEG 8000, including repackagers and relabelers. The FDA regulates PEG 8000 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. PEG 8000 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of PEG 8000 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

PEG 8000 Suppliers

A PEG 8000 supplier is an individual or a company that provides PEG 8000 active pharmaceutical ingredient (API) or PEG 8000 finished formulations upon request. The PEG 8000 suppliers may include PEG 8000 API manufacturers, exporters, distributors and traders.

click here to find a list of PEG 8000 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

PEG 8000 USDMF

A PEG 8000 DMF (Drug Master File) is a document detailing the whole manufacturing process of PEG 8000 active pharmaceutical ingredient (API) in detail. Different forms of PEG 8000 DMFs exist exist since differing nations have different regulations, such as PEG 8000 USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A PEG 8000 DMF submitted to regulatory agencies in the US is known as a USDMF. PEG 8000 USDMF includes data on PEG 8000's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The PEG 8000 USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of PEG 8000 suppliers with USDMF on PharmaCompass.

PEG 8000 JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The PEG 8000 Drug Master File in Japan (PEG 8000 JDMF) empowers PEG 8000 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the PEG 8000 JDMF during the approval evaluation for pharmaceutical products. At the time of PEG 8000 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of PEG 8000 suppliers with JDMF on PharmaCompass.

PEG 8000 WC

A PEG 8000 written confirmation (PEG 8000 WC) is an official document issued by a regulatory agency to a PEG 8000 manufacturer, verifying that the manufacturing facility of a PEG 8000 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting PEG 8000 APIs or PEG 8000 finished pharmaceutical products to another nation, regulatory agencies frequently require a PEG 8000 WC (written confirmation) as part of the regulatory process.

click here to find a list of PEG 8000 suppliers with Written Confirmation (WC) on PharmaCompass.

PEG 8000 NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing PEG 8000 as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for PEG 8000 API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture PEG 8000 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain PEG 8000 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a PEG 8000 NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of PEG 8000 suppliers with NDC on PharmaCompass.

PEG 8000 GMP

PEG 8000 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of PEG 8000 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right PEG 8000 GMP manufacturer or PEG 8000 GMP API supplier for your needs.

PEG 8000 CoA

A PEG 8000 CoA (Certificate of Analysis) is a formal document that attests to PEG 8000's compliance with PEG 8000 specifications and serves as a tool for batch-level quality control.

PEG 8000 CoA mostly includes findings from lab analyses of a specific batch. For each PEG 8000 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

PEG 8000 may be tested according to a variety of international standards, such as European Pharmacopoeia (PEG 8000 EP), PEG 8000 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (PEG 8000 USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty